Manulife (Manufacturers Life Insurance)
GLUE icon

Manulife (Manufacturers Life Insurance)’s Monte Rosa Therapeutics GLUE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.45M Buy
209,801
+75,127
+56% +$1.44M ﹤0.01% 1285
2025
Q4 		$2.15M Buy
134,674
+16,291
+14% +$220K ﹤0.01% 1489
2025
Q3 		$877K Sell
118,383
-1,453
-1% -$7.7K ﹤0.01% 1925
2025
Q2 		$540K Buy
119,836
+2,529
+2% +$11.3K ﹤0.01% 2147
2025
Q1 		$544K Sell
117,307
-105
-0.1% -$644 ﹤0.01% 2103
2024
Q4 		$815K Sell
117,412
-465
-0.4% -$3.49K ﹤0.01% 2000
2024
Q3 		$625K Buy
117,877
+15,168
+15% +$76.6K ﹤0.01% 2164
2024
Q2 		$384K Sell
102,709
-378
-0.4% -$1.93K ﹤0.01% 2316
2024
Q1 		$727K Sell
103,087
-1,456
-1% -$8.63K ﹤0.01% 2034
2023
Q4 		$591K Hold
104,543
– – ﹤0.01% 2102
2023
Q3 		$501K Buy
104,543
+26
+0% +$167 ﹤0.01% 2141
2023
Q2 		$716K Buy
104,517
+1,267
+1% +$8.19K ﹤0.01% 1830
2023
Q1 		$804K Hold
103,250
– – ﹤0.01% 1732
2022
Q4 		$759K Sell
103,250
-99
-0.1% -$825 ﹤0.01% 1744
2022
Q3 		$814K Sell
103,349
-556
-0.5% -$5.11K ﹤0.01% 1697
2022
Q2 		$1.02M Buy
103,905
+11,688
+13% +$117K ﹤0.01% 1640
2022
Q1 		$1.26M Buy
+92,217
New +$1.28M ﹤0.01% 1648

Other funds holding GLUE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s GLUE Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Monte Rosa Therapeutics (GLUE) stake by 56% in Q1 2026, buying an estimated $1.44M and bringing the position to 209,801 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1285.

Manulife (Manufacturers Life Insurance) first reported a position in GLUE in Q1 2022 and has held it in 17 quarters since. 190 funds tracked by Wall St. Rank hold GLUE as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 209,801 shares of Monte Rosa Therapeutics worth $3.45M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 75,127 Monte Rosa Therapeutics shares in Q1 2026, an estimated $1.44M.
  • Monte Rosa Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1285 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Monte Rosa Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.